Ratings GoodRx Holdings, Inc.

Equities

GDRX

US38246G1085

Real-time Estimate Cboe BZX Other stock markets 02:32:33 2024-05-23 pm EDT			5-day change	1st Jan Change
7.215 ^USD	+0.21%		-10.05%	+8.21%

02:45pm	RBC Upgrades GoodRx Holdings to Outperform From Sector Perform, Boosts Price Target to $10 From $8	MT
May. 20	Barclays Adjusts Price Target on GoodRx to $10 From $9, Maintains Overweight Rating	MT

Summary

The company has strong fundamentals. More than 70% of companies have a lower mix of growth, profitability, debt and visibility.
Overall, and from a short-term perspective, the company presents an interesting fundamental situation.

Strengths

The company's profit outlook over the next few years is a strong asset.
Before interest, taxes, depreciation and amortization, the company's margins are particularly high.
Thanks to a sound financial situation, the firm has significant leeway for investment.
Sales forecast by analysts have been recently revised upwards.
For the past year, analysts covering the stock have been revising their EPS expectations upwards in a significant manner.
For the last 4 months, the company has been enjoying highly positive EPS revisions, which were frequently and significantly raised.
The difference between current prices and the average target price is rather important and implies a significant appreciation potential for the stock.
Over the past four months, analysts' average price target has been revised upwards significantly.
The opinion of analysts covering the stock has improved over the past four months.
Over the past twelve months, analysts' opinions have been strongly revised upwards.

Weaknesses

The company's valuation in terms of earnings multiples is rather high. Indeed, the firm is getting paid 70.03 times its estimated earnings per share for the ongoing year.
The company's enterprise value to sales, at 3.43 times its current sales, is high.
In relation to the value of its tangible assets, the company's valuation appears relatively high.
For the last twelve months, the trend in sales revisions has been clearly going down, which emphasizes downgraded expectations from the analysts.
Sales estimates for the next fiscal years vary from one analyst to another. This clearly highlights a lack of visibility into the company's future activity.
The price targets of analysts who cover the stock differ significantly. This implies difficulties in evaluating the company and its business.
Financial statements have repeatedly disappointed market stakeholders. Most often, they were below expectations.

Ratings chart - Surperformance

Sector: Internet Services

	1st Jan change	Capi.	ESG Refinitiv
GOODRX HOLDINGS, INC.	+8.21%	2.7B	-
TENCENT HOLDINGS LIMITED	+30.04%	457B	B
NETFLIX, INC.	+29.87%	276B	D+
UBER TECHNOLOGIES, INC.	+3.14%	137B	A-
PROSUS N.V.	+29.39%	93.68B	B+
AIRBNB, INC.	+4.03%	90.6B	C-
SPOTIFY TECHNOLOGY S.A.	+59.32%	59.25B	B-
DOORDASH, INC.	+10.97%	45.65B	C+
NASPERS LIMITED	+24.63%	37.59B	C+
COSTAR GROUP, INC.	-2.03%	35.62B	B

Investor Rating

Trading Rating

ESG Refinitiv

Financials

Sales growth

Earnings Growth

EBITDA / Sales

Profitability

Finances

Valuation

P/E ratio

EV / Sales

Price to Book

Price to Free Cash Flow

Yield

Momentum

1 year Revenue revision

4 months Revenue revision

7 days Revenue revision

1 year EPS revision

4 months EPS revision

Consensus

Analyst Opinion

Potential Price Target

4m Target Price Revision

4m Revision of opinion

12m Revision of opinion

Business Predictability

Analyst Coverage

Divergence of Estimates

Divergence of analysts' opinions

Divergence of Target Price

Earnings quality

Technical analysis

ST Timing

MT Timing

LT Timing

RSI

Bollinger Spread

Unusual volumes